CATALOGO DEI PRODOTTI DELLA RICERCA

GASTALDON, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.976
EU - Europa 2.540
AS - Asia 2.182
SA - Sud America 338
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 78
OC - Oceania 20
Totale 9.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.826
RU - Federazione Russa 1.061
SG - Singapore 894
IT - Italia 497
CN - Cina 483
GB - Regno Unito 318
BR - Brasile 267
VN - Vietnam 224
HK - Hong Kong 218
FR - Francia 120
DE - Germania 116
IE - Irlanda 111
SE - Svezia 107
CA - Canada 97
BD - Bangladesh 94
FI - Finlandia 76
KR - Corea 62
IN - India 41
ID - Indonesia 35
AR - Argentina 30
ES - Italia 26
MX - Messico 22
NL - Olanda 20
TR - Turchia 19
UA - Ucraina 19
JP - Giappone 16
AU - Australia 15
PL - Polonia 15
BJ - Benin 14
NG - Nigeria 14
PK - Pakistan 14
TG - Togo 14
IQ - Iraq 13
MY - Malesia 13
AT - Austria 12
VE - Venezuela 11
EC - Ecuador 8
PH - Filippine 8
ZA - Sudafrica 8
MA - Marocco 7
RO - Romania 7
BE - Belgio 6
CO - Colombia 6
LT - Lituania 6
SA - Arabia Saudita 6
CR - Costa Rica 5
ET - Etiopia 5
JM - Giamaica 5
KE - Kenya 5
LB - Libano 5
NZ - Nuova Zelanda 5
PE - Perù 5
SY - Repubblica araba siriana 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
CL - Cile 4
EE - Estonia 4
GR - Grecia 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
IL - Israele 3
IR - Iran 3
NP - Nepal 3
PT - Portogallo 3
TN - Tunisia 3
AG - Antigua e Barbuda 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
HT - Haiti 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 9.132
Salva come PNG Salva come JPEG
Città #
Ashburn 559
Singapore 498
San Jose 431
Moscow 377
Dallas 296
Southend 219
Hong Kong 205
Chandler 202
Verona 134
Council Bluffs 129
New York 126
Beijing 101
Dublin 99
The Dalles 89
Los Angeles 75
Santa Clara 69
Ho Chi Minh City 67
Jacksonville 56
Woodbridge 51
Princeton 40
Lawrence 38
Munich 37
Atlanta 35
Hanoi 35
Milan 34
Rome 33
Buffalo 32
Helsinki 31
São Paulo 31
Houston 29
Lappeenranta 29
Wilmington 29
Jakarta 28
Brooklyn 25
Columbus 24
Redondo Beach 24
London 22
Montreal 22
San Francisco 22
Chicago 21
Jinan 21
Orem 21
Washington 21
Phoenix 20
Seattle 20
Boston 19
Sindelfingen 19
Toronto 19
Dong Ket 18
Denver 17
Frankfurt am Main 15
Guangzhou 15
McKinney 15
Abuja 14
Boardman 14
Cotonou 14
Lomé 14
Nanjing 14
Shenyang 14
Nuremberg 13
Redwood City 13
Turin 13
Kent 12
Tokyo 12
Zhengzhou 12
Rio de Janeiro 11
Amsterdam 10
Dearborn 10
Tianjin 10
Warsaw 10
Changsha 9
Mexico City 9
Cleveland 8
Curitiba 8
Da Nang 8
Istanbul 8
Manchester 8
Padova 8
Poplar 8
Stockholm 8
Taizhou 8
Bologna 7
Chennai 7
Haikou 7
Madrid 7
Miami 7
Nanchang 7
Bari 6
Dhaka 6
Hangzhou 6
Johannesburg 6
Las Vegas 6
Nepean 6
Norwalk 6
Palermo 6
Redmond 6
Reggio Emilia 6
Thái Bình 6
Vancouver 6
Vienna 6
Totale 5.064
Salva come PNG Salva come JPEG
Nome #
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 359
VORTIOXETINE VERSUS SSRIs FOR THE TREATMENT OF DEPRESSION IN THE ELDERLY: A PRAGMATIC RANDOMIZED CLINICAL TRIAL 299
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 282
Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studies 274
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 265
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 253
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 210
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 207
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 199
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 197
Antipsychotic drug exposure and risk of myocardial infarction 196
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 177
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review 177
Benzodiazepines and risk of dementia: true association or reverse causation? 174
Antipsychotic combinations in schizophrenia 171
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 168
Can a digital medicine system improve adherence to antipsychotic treatment? 161
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 160
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 158
Paroxetine versus other anti-depressive agents for depression 155
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 153
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 151
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 151
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 146
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 146
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database 144
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 144
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 143
Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis 139
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 135
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 133
Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises 133
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 133
Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality 130
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 128
Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis 127
A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome 127
Fluoxetine versus other types of pharmacotherapy for depression 122
Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises 114
Mediators of focused psychosocial support interventions for children in low-resource humanitarian settings: analysis from an Individual Participant Dataset with 3,143 participants 113
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis 111
Esketamine clinical trials: reply to Maju et al 106
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 100
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies 95
Efficacy of psychological interventions for PTSD in distinct populations - An evidence map of meta-analyses using the umbrella review methodology 93
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 92
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 92
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 90
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 89
Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system 88
Peripartum allopregnanolone blood concentrations and depressive symptoms: a systematic review and individual participant data meta-analysis 86
Psychotherapeutic treatments for depression in older adults 84
Polycystic ovary syndrome and postpartum depression: A systematic review and meta-analysis of observational studies 83
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 82
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 81
Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises 80
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 77
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 72
Psychological and social interventions for the promotion of mental health in people living in low- and middle-income countries affected by humanitarian crises 70
Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis 69
History of miscarriage and postpartum depression: a systematic review and meta-analysis of observational studies 69
Postpartum hemorrhage and postpartum depression: A systematic review and meta-analysis of observational studies 67
Reply to the Comments by Doherty et al 65
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 63
Esketamine for treatment-resistant depression in adults 61
Mental health service coverage and gaps among adults in Europe: a systematic review 44
Efficacy and safety of esketamine for "treatment resistant depression": registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials 37
Precipitants and clinical features of serotonin syndrome: a systematic review with patient-level analysis of published case reports and series 35
Paternal exposure to antiseizure medications and offspring outcomes: a systematic review and meta-analysis of observational studies 34
Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBase 32
Comparative effect of different surgical treatments for ovarian endometrioma on anti-Müllerian hormone levels: a systematic review and network meta-analysis 23
Apixaban, direct oral anticoagulants and psychiatric events: Innocent bystander or true safety signal? 17
Safe discontinuation of antidepressants in individuals with clinically remitted depressive disorders: study protocol for a randomised controlled trial 12
Totale 9.253
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.573
article - articoli 33.821
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 752
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022193 0 0 0 19 24 4 9 14 12 3 33 75
2022/2023646 40 60 72 103 57 146 12 46 86 4 17 3
2023/2024555 21 44 37 51 63 117 24 40 9 20 86 43
2024/20251.394 67 77 101 232 75 66 45 85 169 142 102 233
2025/20264.255 284 190 326 637 994 281 422 254 316 261 139 151
2026/20271.475 111 176 278 910 0 0 0 0 0 0 0 0
Totale 9.253